Sequencing Consumables Market Size & Growth Forecast 2027–2036, By Segments (Platform, Product, End-use, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Sequencing Consumables Market size was worth USD 12.6 billion in 2026 and is expected to grow at a 22.42% CAGR between 2027 and 2036, reaching USD 95.26 billion by 2036. The industry revenue for 2027 is calculated at USD 14.98 billion.
Get more details on this report
Request Free Sample ReportSequencing Consumables Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 55.24% share in 2026, driven by established sequencing infrastructure, high testing volumes, and recurring demand for reagents, flow cells, and library preparation kits.
- Asia Pacific is projected to grow at a 24.64% CAGR, supported by expanding sequencing capacity, wider laboratory adoption, and increasing workflow activity across healthcare and research environments.
Segment Momentum
- 2nd Generation Sequencing Consumables held a 64.86% share in 2026 due to their compatibility with widely installed sequencing platforms, validated workflows, and recurring procurement needs in high-volume laboratory operations.
- Reagents are the fastest-growing product segment as laboratories seek greater flexibility to customize workflows, optimize protocols, and manage consumable replenishment across diverse sequencing applications.
Market Expansion Drivers
- Rapid advancements in sequencing technologies increasing genomics research and clinical testing volumes.
- Expanding cancer diagnostics applications accelerating demand for high-throughput sequencing consumables.
- Growing adoption of personalized medicine driving recurring demand for sequencing reagent kits.
Leading Market Participants
- Major companies in the sequencing consumables market include Thermo Fisher Scientific Inc. (United States), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (United States), Merck KGaA (Germany), Takara Bio Inc. (Japan), Oxford Nanopore Technologies plc (United Kingdom), Beckman Coulter, Inc. (United States), BGI Genomics Co., Ltd. (China), Illumina, Inc. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 12.6 billion
- 2027 Estimated Market Size: USD 14.98 billion.
- Projected Market Size: USD 95.26 billion by 2036
- Growth Forecast: 22.42% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: 2nd Generation Sequencing Consumables (Platform) | Kits (Product) | Hospitals and Laboratories (End-use) | Cancer Diagnostics (Application)
- Emerging Opportunity Segment: 3rd Generation Sequencing Consumables (Platform) | Reagents (Product) | Pharmaceutical and Biotechnology Companies (End-use) | Pharmacogenomics (Application)
Market Growth Drivers and Industry Trends
Rapid advancements in sequencing technologies increasing genomics research and clinical testing volumes
Rapid innovation in sequencing platforms is expanding the range of applications across genomics research, molecular analysis, and clinical testing. The sequencing consumables market will be driven by the increasing use of reagents, kits, cartridges, and other consumable components required to perform sequencing workflows as laboratories adopt newer technologies. Improvements in sequencing capabilities can also enable researchers and diagnostic laboratories to process increasingly complex biological information, creating recurring requirements for consumables throughout sample preparation and sequencing procedures.
Expanding cancer diagnostics applications accelerating demand for high-throughput sequencing consumables
The growing use of sequencing in cancer diagnostics is increasing the need for technologies capable of analyzing genetic alterations associated with disease development and treatment selection. High-throughput applications are particularly relevant as laboratories process larger numbers of samples and seek detailed genomic information for diagnostic evaluation. Consequently, the sequencing consumables market is supported by recurring consumption of reagents and workflow-specific materials required to perform molecular analyses efficiently across cancer testing applications.
Growing adoption of personalized medicine driving recurring demand for sequencing reagent kits
Personalized medicine increasingly relies on molecular information to characterize individual patient profiles and support more targeted healthcare decisions. As sequencing becomes integrated into these approaches, the sequencing consumables market will gain from repeated use of reagent kits required for sample processing, library preparation, sequencing, and related genomic workflows. The need to evaluate individual biological characteristics across different patients and clinical applications creates ongoing consumption requirements as laboratories conduct sequencing-based analyses.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rapid advancements in sequencing technologies increasing genomics research and clinical testing volumes | 2.00% | Moderate | North America, Asia Pacific, Europe | High | Near Term |
| Expanding cancer diagnostics applications accelerating demand for high-throughput sequencing consumables | 1.90% | High | North America, Europe | High | Mid Term |
| Growing adoption of personalized medicine driving recurring demand for sequencing reagent kits | 1.60% | High | Asia Pacific, North America | High | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held a 55.24% share of the sequencing consumables market in 2026, reflecting its strong genomics research ecosystem and extensive use of sequencing technologies across academic, clinical, and pharmaceutical applications. Continued activity in precision medicine, molecular diagnostics, and biomedical research generates recurring demand for reagents, kits, and other consumables required throughout sequencing workflows. Advanced laboratory infrastructure, strong research capabilities, and ongoing integration of genomic analysis into healthcare and life sciences support the region's leading position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific represents the fastest-growing regional market, supported by expanding genomics research, improving laboratory infrastructure, and increasing adoption of sequencing technologies across healthcare and biotechnology applications. Growing interest in precision medicine and molecular diagnostics is encouraging broader use of sequencing workflows, which in turn drives recurring consumables demand. Investments in research capabilities, healthcare modernization, and the development of local biotechnology ecosystems are creating favorable conditions for sustained regional expansion.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Genomics IntegrationGermany advances the sequencing consumables market through strong adoption of genomic technologies in research institutions and clinical laboratories. Demand in Germany increasingly focuses on high-quality consumables that support reproducible sequencing workflows and precision medicine applications.
France 🇫🇷
Translational Research SupportFrance supports the sequencing consumables market through collaborative research programs linking genomic discovery with clinical practice. Laboratories in France continue adopting consumables that enable efficient sequencing workflows across academic, healthcare, and life science research settings.
Italy 🇮🇹
Laboratory Workflow EnhancementItaly continues expanding sequencing capabilities across research institutes and diagnostic laboratories, supporting sustained demand for specialized consumables. The sequencing consumables market in Italy prioritizes dependable product quality and workflow consistency as genomic testing applications broaden.
Japan 🇯🇵
Clinical Sequencing AdoptionJapan continues integrating sequencing technologies into healthcare and biomedical research, supporting consistent demand for specialized consumables. The sequencing consumables market in Japan emphasizes quality assurance, standardized laboratory practices, and efficient genomic testing workflows.
South Korea 🇰🇷
Genomics Research ExpansionSouth Korea strengthens the sequencing consumables market through investments in genomic research infrastructure and biotechnology development. Laboratories across South Korea increasingly require dependable consumables that support expanding sequencing applications in research and clinical environments.
United States 🇺🇸
High-Throughput Research DemandThe U.S. sequencing consumables market is driven by extensive genomic research, clinical sequencing programs, and biotechnology innovation. Laboratories in the U.S. prioritize reliable consumable supply, workflow efficiency, and compatibility with advanced sequencing platforms.
Segment Leadership and Growth Trends
Sequencing Consumables Market Share (%), by Platform, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportPlatform Segment Analysis: 2nd Generation Sequencing Consumables (Largest Segment) vs 3rd Generation Sequencing Consumables (Fastest-Growing Segment)
The 2nd generation sequencing consumables segment led the sequencing consumables market with a 64.86% share in 2026, supported by its established use across research, clinical, and genomics applications. The broad installed base of second-generation sequencing platforms creates recurring demand for consumables required for sample preparation, sequencing workflows, and downstream analysis. Their ability to support high-throughput processing and large-scale studies continues to make these consumables important for applications such as disease research, genetic testing, and population genomics, reinforcing the segment's leading position.
3rd generation sequencing consumables are expected to represent the fastest-growing segment as demand increases for technologies capable of delivering longer reads and more detailed genomic information. These consumables support emerging sequencing workflows designed to improve the analysis of complex genetic structures and reduce certain limitations associated with conventional short-read approaches. Expanding interest in precision medicine, advanced genomics research, and real-time sequencing applications is likely to strengthen adoption as laboratories seek more comprehensive and efficient approaches to genomic analysis.
Product Segment Analysis: Kits (Largest Segment) vs Reagents (Fastest-Growing Segment)
Kits accounted for the largest share of the sequencing consumables market at 77.05% in 2026, reflecting the strong preference for standardized and workflow-ready solutions. Sequencing kits simplify complex laboratory procedures by providing the required components in integrated formats, helping laboratories improve consistency, reduce preparation time, and minimize the risk of workflow variability. Their widespread use across sample preparation and sequencing processes also supports recurring demand as genomics research and clinical testing activities continue to expand.
Reagents are anticipated to be the fastest-growing product segment, driven by the increasing volume and diversity of sequencing procedures that require specialized chemical and biological inputs. As laboratories adopt more advanced sequencing workflows and tailor protocols for different applications, demand for reagents that support accuracy, sensitivity, and workflow optimization is expected to increase. Continued innovation in sequencing technologies and the growing use of genomics across research and healthcare are likely to further strengthen consumption of sequencing reagents.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Platform | 1st Generation Sequencing Consumables, 2nd Generation Sequencing Consumables, 3rd Generation Sequencing Consumables | 2nd Generation Sequencing Consumables | 3rd Generation Sequencing Consumables |
| Product | Kits, Reagents, Accessories | Kits | Reagents |
| End-use | Pharmaceutical and Biotechnology Companies, Hospitals and Laboratories, Academic Research Institutes, Others | Hospitals and Laboratories | Pharmaceutical and Biotechnology Companies |
| Application | Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics, Others | Cancer Diagnostics | Pharmacogenomics |
Competitive Landscape and Market Positioning
Top players in the sequencing consumables market:
1. Thermo Fisher Scientific Inc. (United States)
2. F. Hoffmann-La Roche Ltd. (Switzerland)
3. QIAGEN N.V. (Netherlands)
4. Agilent Technologies Inc. (United States)
5. Merck KGaA (Germany)
6. Takara Bio Inc. (Japan)
7. Oxford Nanopore Technologies plc (United Kingdom)
8. Beckman Coulter Inc. (United States)
9. BGI Genomics Co. Ltd. (China)
10. Illumina Inc. (United States)
The sequencing consumables market is benefiting from rising genomic research activity and increasing adoption of precision medicine technologies. Companies are expanding consumable portfolios with high-throughput reagents and workflow-optimized products that support faster and more accurate sequencing processes. Continuous investment in research and laboratory automation is also driving innovation across the sequencing consumables market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. (United States) | |||||||
| F. Hoffmann-La Roche Ltd. (Switzerland) | |||||||
| QIAGEN N.V. (Netherlands) | |||||||
| Agilent Technologies Inc. (United States) | |||||||
| Merck KGaA (Germany) | |||||||
| Takara Bio Inc. (Japan) | |||||||
| Oxford Nanopore Technologies plc (United Kingdom) | |||||||
| Beckman Coulter Inc. (United States) | |||||||
| BGI Genomics Co. Ltd. (China) | |||||||
| Illumina Inc. (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| QIAGEN | Jul-25 | QIAGEN launched its QIAseq xHYB Long Read Panels in the Netherlands to advance next-generation sequencing capabilities. The rollout directly addresses growing clinical and research demand for specialized sequencing consumables optimized for complex genomic regions. |
| Illumina, Inc. | Jan-25 | Illumina, Inc. commercialized an update to its NovaSeq X Series, launching a single-flow-cell system alongside advanced operating software and new sequencing kits. The release scales workflow flexibility and updates high-throughput consumable options for global laboratory networks. |
| Illumina Inc. | Nov-23 | Illumina Inc. introduced the Global Health Access Initiative in collaboration with the nonprofit FIND to expand access to sequencing tools. The program implements a tiered, reduced pricing structure for select sequencing consumables and addresses international supply chain constraints across low- and middle-income nations. |
| Thermo Fisher Scientific Inc. | May-23 | Thermo Fisher Scientific and Pfizer established a strategic collaboration to expand local patient access to next-generation sequencing-based testing across more than 30 countries. The initiative enhances diagnostic capabilities for lung and breast cancer within historically underserved markets in Latin America, Africa, the Middle East, and Asia. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Sequencing Consumables Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Sequencing Workflow Stage | Sample Preparation & Library Preparation, Sequencing & Run Consumables, Post-Sequencing Processing |
| Sample Type | Genomic DNA, RNA, Cell-Free DNA, Microbial & Environmental Samples, Other Biological Samples |
| Purchase Model | Direct Purchase, Distributor-Based Purchase, Reagent Rental/Consumables-Linked Agreements |
Sequencing Consumables Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Sequencing Platform Compatibility Landscape |
|
| Laboratory Purchasing Behavior and Consumables Adoption Analysis |
|
| Companion Diagnostics and Clinical Genomics Adoption Outlook |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market size of sequencing consumables?
How is the sequencing consumables industry expected to grow over the next 10 years?
How are advances in sequencing technologies influencing recurring demand in the sequencing consumables market?
Why is personalized medicine strengthening long-term demand for sequencing consumables?
Why do 2nd Generation Sequencing Consumables hold the largest share of the sequencing consumables market?
What is driving the rapid growth of reagents in the sequencing consumables market?
Why does North America lead the sequencing consumables market?
How is Asia Pacific driving future growth in sequencing consumables demand?
Which organizations are considered leaders in the sequencing consumables landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization